TORONTO, ONTARIO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – With the high demand for Covid-19 testing, BioLife Sciences (OTCPK: BLFE) is pleased to announce the availability of the FebriDx® ...
With our media embedded in 16 approved therapies and supporting more than 250 ongoing commercial trials, including over 30 in Phase III, we've established BioLife as the default partner for clinical ...
We have been happy that BioLife Solutions (BLFS) has gone back to basics and is concentrating (mostly) on what is its most important segment, the biopreservation media (which is 85% of its cell ...
Bothell, Washington-based BioLife Solutions reports its SciSafe biostorage services platform now offers a fleet of refrigerated and ultra-low temperature (ULT) truck-trailers to manage local cold ...
Hosted on MSN
BioLife Solutions raises 2025 revenue guidance to $96M as cell processing momentum accelerates
CEO Roderick de Greef highlighted strong quarterly performance, stating that "cell processing revenue increased 33% year-over-year, driving a 31% increase in total revenue for the quarter." He ...
Chief Executive Officer and Chairman of the Board — Roderick de Greef Chief Financial Officer — Troy Wichterman Roderick de Greef: Thanks, Troy. Good afternoon, and thank you for joining us for ...
Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the BioLife Solutions Third Quarter 2025 Shareholder and Analyst Conference Call. [Operator Instructions] I will now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback